Exact Mass: 383.2249

Exact Mass Matches: 383.2249

Found 51 metabolites which its exact mass value is equals to given mass value 383.2249, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

(1R,7S)-4-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]deca-2,5-diene-3,5-diol

(1R,7S)-4-[4-(4-Pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]deca-2,5-diene-3,5-diol

C21H29N5O2 (383.2321)


   

Tandospirone

2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione

C21H29N5O2 (383.2321)


   

Trecadrine

2-[methyl(2-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}ethyl)amino]-1-phenylpropan-1-ol

C27H29NO (383.2249)


   

Cyclomarazine B

Cyclomarazine B

C22H29N3O3 (383.2209)


   

CHEMBL564302

CHEMBL564302

C27H29NO (383.2249)


   
   
   
   

9-(3-isovaleryl)viridifloryl retronecine

9-(3-isovaleryl)viridifloryl retronecine

C20H33NO6 (383.2308)


   

Nb-methyl-3alpha-amino-seco-voacarpine

Nb-methyl-3alpha-amino-seco-voacarpine

C22H29N3O3 (383.2209)


   

(+)-lanatine A|(4S,6R,7S,13S)-13-oxyanthranoyllupanine

(+)-lanatine A|(4S,6R,7S,13S)-13-oxyanthranoyllupanine

C22H29N3O3 (383.2209)


   
   
   
   
   
   

CAY10598

5-[(3S)-3-hydroxy-4-phenyl-1-buten-1-yl]1-[6-(2H-tetrazol-5R-yl)hexyl]-2-pyrrolidinone

C21H29N5O2 (383.2321)


   
   
   
   

Tandospirone

Tandospirone

C21H29N5O2 (383.2321)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Tandospirone (SM-3997) is a potent and selective 5-HT1A receptor partial agonist, with a Ki of 27 nM. Tandospirone has anxiolytic and antidepressant activities. Tandospirone can be used for the research of the central nervous system disorders and the underlying mechanisms[1][2][3].

   

Benzododecinium Bromide

Benzyldodecyldimethylammonium Bromide

C21H38BrN (383.2187)


D013501 - Surface-Active Agents > D003902 - Detergents > D001548 - Benzalkonium Compounds C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D000890 - Anti-Infective Agents D004202 - Disinfectants

   

6-[(2-Nitrophenyl)azo]-2,4-di-tert-pentylphenol

6-[(2-Nitrophenyl)azo]-2,4-di-tert-pentylphenol

C22H29N3O3 (383.2209)


   

[3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrol-1-yl]-tri(propan-2-yl)silane

[3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrol-1-yl]-tri(propan-2-yl)silane

C19H35BClNO2Si (383.2219)


   

Cetylpyridinium Bromide

Cetylpyridinium Bromide

C21H38BrN (383.2187)


C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent

   

(Methylpyridazine piperidine propyloxyphenyl)ethylacetate

(Methylpyridazine piperidine propyloxyphenyl)ethylacetate

C22H29N3O3 (383.2209)


   

N-[1-(cyclohexylamino)-2-methyl-1-oxobutan-2-yl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

N-[1-(cyclohexylamino)-2-methyl-1-oxobutan-2-yl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

C22H29N3O3 (383.2209)


   

2-(3,5-Dimethyl-1-pyrazolyl)-1-[3-[oxo-(3-propan-2-yloxyphenyl)methyl]-1-piperidinyl]ethanone

2-(3,5-Dimethyl-1-pyrazolyl)-1-[3-[oxo-(3-propan-2-yloxyphenyl)methyl]-1-piperidinyl]ethanone

C22H29N3O3 (383.2209)


   

soppiline C anion

soppiline C anion

C24H31O4- (383.2222)


   

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-7-(1-cyclohexenyl)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C22H29N3O3 (383.2209)


   

(2S,3S,3aR,9bR)-7-(cyclohexen-1-yl)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-7-(cyclohexen-1-yl)-N-(cyclopropylmethyl)-3-(hydroxymethyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide

C22H29N3O3 (383.2209)


   

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-8-(4-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-8-(4-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O3 (383.2209)


   

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-8-(4-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-8-(4-methylphenyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O3 (383.2209)


   

cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone

cyclobutyl-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C22H29N3O3 (383.2209)


   

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone

C22H29N3O3 (383.2209)


   

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone

cyclobutyl-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone

C22H29N3O3 (383.2209)


   

2-[(2-Acetamido-3-hydroxynonoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Acetamido-3-hydroxynonoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C16H36N2O6P+ (383.2311)


   

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-[3-hydroxy-2-(propanoylamino)octoxy]phosphoryl]oxyethyl-trimethylazanium

C16H36N2O6P+ (383.2311)


   

soppiline C(1-)

soppiline C(1-)

C24H31O4 (383.2222)


A hydroxy monocarboxylic acid anion that is the conjugate base of soppiline C, arising from the deprotonation of the carboxy group. Major species at pH 7.3.

   
   

ST 18:0;O4;Gly

ST 18:0;O4;Gly

C20H33NO6 (383.2308)


   

Usmarapride (free base)

Usmarapride (free base)

C21H29N5O2 (383.2321)


Usmarapride (SUVN-D4010) free base is a potent, selective, orally active and brain penetrant 5-HT4 receptor partial agonist (EC50=44 nM). Usmarapride (SUVN-D4010) free base can be used for the research of cognitive deficits associated with Alzheimer's disease[1].

   

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-aminobenzoate

(1s,2s,4s,9s,10r)-14-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadecan-4-yl 2-aminobenzoate

C22H29N3O3 (383.2209)


   

methyl (1s,12r,14s,15e,18s)-12-amino-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

methyl (1s,12r,14s,15e,18s)-12-amino-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C22H29N3O3 (383.2209)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate

C20H33NO6 (383.2308)


   

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

7-{[(2,3-dihydroxy-2-isopropylbutanoyl)oxy]methyl}-hexahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

C20H33NO6 (383.2308)


   

methyl 12-amino-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

methyl 12-amino-15-ethylidene-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C22H29N3O3 (383.2209)


   

(1r,2s,12s,15s)-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-1,2-diol

(1r,2s,12s,15s)-7-methoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-1,2-diol

C22H29N3O3 (383.2209)


   

(1r,7s,7as)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1r,7s,7as)-7-({[(2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoyl]oxy}methyl)-hexahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C20H33NO6 (383.2308)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r)-2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2r,3r)-2-hydroxy-2-isopropyl-3-[(3-methylbutanoyl)oxy]butanoate

C20H33NO6 (383.2308)


   

(3s,6s)-3-[(2r)-3-hydroxy-2-methylpropyl]-6-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(2r)-3-hydroxy-2-methylpropyl]-6-{[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl}-3,6-dihydropyrazine-2,5-diol

C22H29N3O3 (383.2209)